Rosfion

Indication : Rosfion is indicated for :
Patients with primary hypercholesterolaemia (type IIa, including heterozygous familial hypercholesterolaemia) or mixed dyslipidemia (type IIb) as an adjunct to diet when response to diet and exercise is inadequate.
Reduces elevated LDL-cholesterol, total cholesterol, triglycerides and ApoB, and increases HDL-cholesterol.
Patients with homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis).

Composition :
Each Rosfion Film coated tablet 10 mg contains Rosuvastatin calcium equivalent to Rosuvastatin 10 mg.
Each Rosfion Film coated tablet 20 mg contains Rosuvastatin calcium equivalent to Rosuvastatin 20 mg.

Presentation :
Rosfion Film coated tablet 10 mg
Box, 3 blisters @ 10 film coated tablets

Rosfion Film coated tablet 20 mg
Box, 3 blisters @ 10 film coated tablets

On medical prescription only
Store below 30°C